Polypharmacy in the heart failure patient: are all prescribed drug classes required?

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1039430

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project investigates the issue of polypharmacy is heart failure. Polypharmacy is the use of four or more prescription medications, and heart failure patients take six on average. This project investigates the evidence for safe withdrawal of medications failure that have not been shown to prolong life in heart, doctor and patient attitudes to withdrawing medications, and then runs a series of three clinical trials, each withdrawing a different medication in heart failure patients and closely monitors the effects.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Postgraduate Scholarships

Funding Amount: $134,110.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

drugs | evidence-based clinical practice | geriatrics | heart failure | therapeutics

Related Links